Fennec Pharmaceuticals Inc (FENC NASDAQ) stock market data APIs
$8.9217
0.15(1.7%)
as of October 24, 2025
Try our APIs with
free plan!
Fennec Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Prev. Close
8.9217
Open
9.0733
High
9.1471
Low
8.8437
52 wk Range
3.96-9.92
Market Cap
252 M
Shares Outstanding
27 832 K
Revenue
33 302 K
EPS
-0.11
Beta
0.637
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Fennec Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Fennec Pharmaceuticals Inc data using free add-ons & libraries
Get Fennec Pharmaceuticals Inc Fundamental Data
Fennec Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 33 302 K
- EBITDA: -9 342 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-14
- EPS/Forecast: -0.04
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Fennec Pharmaceuticals Inc News
New
New Strong Sell Stocks for Oct. 15th
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Adherex Technologies FENC is a clinical-stage biotechnology company which is focused on the development of Sodium Thiosulfat...
Far Eastern New Century Pioneers Footwear Sustainability with World's First Commercialized Midsoles from Waste PET Bottles
TAIPEI, Oct. 2, 2025 /PRNewswire/ -- Far Eastern New Century Corporation (FENC) is a global leader in eco-friendly polyester materials, dedicated to the innovation and development of sustainable mater...
3 Growth Companies With High Insider Ownership Expecting Up To 58% Earnings Growth
As the major U.S. stock indices, including the Nasdaq and S&P 500, show signs of recovery after a challenging week, investors are closely monitoring market movements amid concerns such as potential go...
Fennec Q2 Sales Jump 33 Percent
Fennec Pharmaceuticals (NASDAQ:FENC) reported second quarter 2025 earnings on August 14, 2025, GAAP net product sales of $9.7 million, up 33% year over year compared to the same period last year and 1...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
